Every CEO of a medical-device manufacturer carries a quiet question that doesn’t appear in any quarterly review: if a device left our plant today and harmed a patient six months from now, could we reconstruct exactly what happened — down to the failed component, its lot, its supplier, its date code, and every other device that shared that lot? Could we do it in hours, not weeks? And would the records hold up under FDA scrutiny and the lawyers who will inevitably follow?
You already know the answer should be yes. You also know, if you’re honest, that the answer depends entirely on something quieter and less glamorous than the device itself: the discipline of your records.
This is a piece about that discipline — specifically, where AI agents can genuinely help with it, and where they can’t.
What’s actually at stake
A medical device that reads a patient’s blood pressure as low when it’s high is not an abstract failure mode. It changes the medication the clinician orders. In an ICU, it can change whether the patient survives. The CEO is accountable — personally, legally, reputationally — and the first hours after an adverse event report determine whether your company is seen as a careful manufacturer that can demonstrate exactly what happened, or one that struggles to explain itself under pressure.
The thing that determines which of those you become is not the device. The device has already done what it did. The thing that determines it is whether your traceability chain — from finished unit back through every component, every lot, every supplier, every record of every test — is intact and reachable. Traceability is the difference between “here is exactly what occurred and exactly which units could be affected” and “we’re still investigating.” One of those protects patients, the company, and you. The other does not.
Traceability is the work you do before anything goes wrong that determines what you can prove after something does. By then, it’s too late to start.
Where agents fit — and where they don’t
Before we go further, it’s worth being precise about something: an AI agent cannot prevent a device malfunction. The integrity of the device itself is a function of design, components, firmware, testing, and manufacturing — and no agent changes any of that. Anyone selling you AI as a safeguard against device failure is selling you something we wouldn’t.
What agents can do — credibly, and inside the same QSR and audit requirements you already operate under — is help the people doing the documentation and investigation work do it more completely and more quickly. There are two distinct places where they earn their keep, and they are different enough that they’re best thought of as two separate agents, scoped and built independently.
Agent one: keeping your traceability chain intact, every day
The first agent operates in the quiet, ongoing work of maintaining device history records (DHRs) and traceability data as devices are built, tested, and released. This is not glamorous work, and it’s exactly the kind of work that drifts when teams are busy. A field is left blank. A lot reference doesn’t quite match a supplier certificate. A component’s date code is missing from one record but present in another. Any single gap is small. The problem is that you don’t know which gap will matter until an adverse event makes it matter — and by then it’s a gap you can’t go back and fill.
An agent in this role doesn’t replace your quality engineers or your document control team. It works alongside them, continuously checking records for completeness as they’re created: confirming that required fields are filled, that lot and serial traceability links are unbroken, that component certificates of conformance are linked to the right records, that DHRs are complete before a batch is released. When something is missing or inconsistent, the agent flags it — to the right human, with full context, while the record is still fresh enough to fix correctly.
The value is not flashy. It is, however, the value that matters most in the moment you most need it: when something goes wrong and your traceability is examined under regulatory and legal pressure, the chain is actually intact, because it has been continuously verified all along — not reconstructed in a panic during an investigation.
This work is fundamentally human-supervised, fully auditable, and operates within your existing quality system. The agent doesn’t make decisions about records; it surfaces what needs attention so the responsible humans can act.
Agent two: reconstructing the history fast, when something happens
The second agent operates in the very different moment of an adverse event or a serious complaint — the moment a CEO genuinely fears. A device is implicated. The clock starts. Regulators expect a response. Lawyers prepare. Other potentially affected units need to be identified before more harm occurs. And the work in front of your quality team is staggering: pull the device’s full DHR, trace the implicated component back to its lot, identify every other unit that included a component from that lot, gather the supplier records, assemble a chronological timeline, surface any prior signals (complaints, NCRs, prior investigations) that might be related.
Done manually, this is days of intense, exhausting work performed under the worst possible conditions, with the entire company waiting. Steps get missed. Records that exist somewhere can’t be found quickly. Connections between data sources get made by hand, one at a time.
An agent in this role works as a force-multiplier for the investigation team. It assembles the relevant records from across your systems, traces component genealogy, identifies the population of potentially affected units, gathers prior history that may be relevant, and produces a structured investigation packet — fast, complete, and with a full audit trail of what it pulled and from where. What previously took days of frantic manual work compresses into hours. More importantly, it compresses with fewer gaps, because an agent does not get tired or rushed or distracted by the pressure of the moment.
Again — and this is essential — the agent assembles and accelerates; it does not decide. The investigation, the root-cause analysis, the regulatory response, the decisions about field action, the communications: all of that remains with your experienced people. The agent gets the information work off their plate so they can focus on the judgment work only they can do.
Why two agents, not one
These are different jobs, with different rhythms, different data, and different risk profiles. The first runs continuously and quietly, as routine as records themselves. The second runs intensely and infrequently, under pressure, with stakes that justify careful, deliberate scoping. Treating them as one tool would compromise both. Treating them as two — built and validated separately — lets each be designed, audited, and trusted for what it actually does.
It also reflects a reality of how good operations are run: the work that prevents the crisis and the work that handles it are different disciplines, even though they share the same records.
What the next step looks like
If this resonates — if you’ve ever thought about how fast and how completely you could reconstruct a device’s history under pressure, and whether your records would hold up to that test — it’s worth a conversation. We’re not going to sell you a safeguard against device failures; no one can. What we can do is sit down with your quality leadership, look honestly at where your traceability discipline is strong and where it has the kinds of small gaps that don’t matter until they do, and identify whether one of these agents — and which one — would help you most.
A 30-minute discovery call. No technical knowledge required. No assumption that you’re behind. Just a clear-eyed look at the records that stand between a device failure and your ability to explain exactly what happened.
Curious where your quality system is on this? Take our 5-minute Readiness Assessment.